Timothy L. Holman

Clozapine‐induced weight gain associated with the 5HT2C receptor −759C/T polymorphism

Del D. Miller, Vicki L. Ellingrod, Timothy L. Holman et al. · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · 2005 · 155 citations

Obesity, Molecular Pharmacology, Body Composition +13

Weight gain associated with the −759C/T polymorphism of the 5HT2C receptor and olanzapine

Vicki L. Ellingrod, Paul J. Perry, John C. Ringold et al. · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · 2005 · 148 citations

Plasma clozapine concentrations as a predictor of clinical response: a follow-up study.

Del D. Miller, Fergal J. Fleming, Timothy L. Holman et al. · PubMed · 1994 · 119 citations

Follow-up Study, Psychiatry, Psychotic Disorder +15

Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants

Vicki L. Ellingrod, Del D. Miller, Stephan F. Taylor et al. · Schizophrenia Research · 2008 · 107 citations · Full text

Insulin Resistance, Metabolic Syndrome, Metabolic Disorder +11

Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults.

S. Kuperman, Paul J. Perry, Gary Gaffney et al. · Annals of Clinical Psychiatry · 2001 · 85 citations

Adhd, Neuropsychology, Adhd Adults +15